Skip to main content

Report

Drug pricing spotlight: Wound care

Combat against brand name products costing 125 times more.

As new medications enter the market, we’ve observed a troubling new trend: an influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value. 

Recently, manufacturers have launched new brand-name prescription wound dressings that include similar combinations of ingredients as OTC and lower-cost generic products yet are priced far higher than the alternatives — up to 125 times more.

This report shines a spotlight on:

  • What’s driving the increased need for wound care.
  • The potential effects of high-cost prescription wound dressings on patients and plan sponsors.
  • How Optum Rx helps improve the quality of care while lowering costs.

Related healthcare insights

View all

Article

Improving transparency in payer-provider connections

Explore how real-time connections can enable more accurate claim submission to create a more efficient healthcare payment system.

Article

How to improve medication adherence 101

Learn strategies for managing members at risk of medication nonadherence, from initiation to renewal.

Article

GLP-1s: Real-life wonder drugs?

Hundreds of clinical trials are vetting GLP-1s to treat everything from Alzheimer’s to arthritis. The question is: How will we afford it?